Can a low-dose computed tomography (CT) chest screening for lung cancer detect pulmonary embolism or pneumonia?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: November 18, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Can Low-Dose CT Chest Screening Detect Pulmonary Embolism or Pneumonia?

Yes, low-dose CT (LDCT) screening for lung cancer can detect pulmonary embolism and pneumonia as incidental findings, though it is not optimized for these diagnoses and should not be used as a primary diagnostic tool for either condition.

Detection Capability

LDCT lung cancer screening is performed as a non-contrast, non-ECG-gated study designed specifically to identify pulmonary nodules. However, it routinely captures the entire thorax and can reveal various incidental findings beyond lung nodules 1, 2.

Pulmonary Embolism Detection

  • LDCT can visualize pulmonary emboli, but with significant limitations
  • The scan is not contrast-enhanced, which is the standard requirement for CT pulmonary angiography (CTPA)
  • Without IV contrast, central and larger pulmonary emboli may be visible as filling defects, but sensitivity is substantially reduced compared to dedicated CTPA
  • Incidental PE detection on cancer screening CT has been documented 3, with studies showing that cancer patients have higher rates of incidental PE (13.8% in cancer patients vs 1.9% in non-cancer patients)
  • If PE is suspected clinically, a dedicated contrast-enhanced CTPA should be ordered rather than relying on screening LDCT 4

Pneumonia Detection

  • LDCT is more reliable for detecting pneumonia than PE, as consolidations and infiltrates are visible on non-contrast imaging
  • Lung parenchymal abnormalities including infectious processes are readily apparent 5
  • However, distinguishing between pneumonia, malignancy, and other inflammatory processes can be challenging on imaging alone
  • The case report literature documents instances where nodules detected on LDCT screening were ultimately diagnosed as infectious lesions rather than malignancy 5

Clinical Implications and Management

Incidental Findings Framework

The screening guidelines emphasize systematic management of incidental findings 2:

  • Screening programs must develop clear protocols for reporting and managing non-nodular findings
  • Responsibility for follow-up must be explicitly assigned (either to the ordering provider or centralized screening program management)
  • Communication should be standardized to minimize anxiety and ensure appropriate action

Key Caveats

Critical pitfall: Do not use LDCT screening as a substitute for diagnostic imaging when PE or pneumonia is clinically suspected. Symptomatic patients should not enter screening programs but should receive appropriate diagnostic testing regardless of screening eligibility 2.

For suspected PE: Order contrast-enhanced CTPA, which can achieve diagnostic quality with reduced radiation (0.4-23.5 mSv) and contrast doses (20-75 ml) 4.

For suspected pneumonia: Standard chest CT or even chest radiography may be more appropriate initial diagnostic tests depending on clinical severity.

Reporting Standards

When incidental findings suggesting PE or pneumonia are detected on screening LDCT 2:

  • Findings should be reported systematically using standardized language
  • Clear follow-up recommendations must be provided
  • The ordering clinician or screening program must ensure diagnostic workup occurs
  • Documentation should specify who assumes responsibility for next steps

Bottom Line

While LDCT lung cancer screening can incidentally detect both pulmonary embolism and pneumonia, it should never be ordered for the primary purpose of diagnosing these conditions. The scan lacks contrast enhancement needed for optimal PE detection and is not designed as a diagnostic tool for acute pulmonary processes. When these findings are discovered incidentally, they require appropriate diagnostic confirmation and clinical correlation.

Related Questions

What is the appropriate workup and initial management for an 88‑year‑old patient with a confirmed unprovoked pulmonary embolism, including laboratory testing, cancer screening, and anticoagulant selection based on renal function?
How should a hospitalized patient with lung cancer and a newly diagnosed pulmonary embolism, who is currently stable without major complications, be treated?
Should an 82-year-old woman with a 30 pack-year smoking history who continues to smoke half a pack per day undergo low-dose CT lung cancer screening?
When should a smoker undergo low‑dose chest CT for lung‑cancer screening and when is a diagnostic chest CT indicated?
How should I manage anticoagulation and other treatments for an 83-year-old female with a history of cancer who has confirmed bilateral pulmonary emboli, a probable urinary tract infection, and macrocytic anemia?
Can you explain peritonitis?
For US paramedics, what are the typical demographics, pathophysiology, signs and symptoms, assessment findings, EMS management (including ABCs, medication use, and transport decisions), and potential complications of eclampsia?
In a middle‑aged adult presenting with fatigue, anorexia, nausea, right‑upper‑quadrant discomfort, dark urine, pale stools, and new‑onset jaundice suggestive of acute viral hepatitis, what are the typical chief complaint, history of present illness, review of systems, physical examination findings, provisional diagnosis, differential diagnosis, recommended investigations, and management?
How does the blood culture system work in a microbiology laboratory?
What are the side effects of Maxgalin (pregabalin)?
I am taking pregabalin (Maxgalin) and experiencing weight gain and dizziness; can I switch to another medication?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.